Financials
- Market Capitalization 14.55 M
- Employee 23
- Founded 2007
- CEO N/A
- Website www.citiuspharma.com
- Headquarter Nevada, United States
- FIGI BBG001QQH2N3
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.42
Relación precio/flujo de caja
3.49
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4707 | HIND Vyome Holdings, Inc. - Common Stock | 2.18 USD | -2.68% | -1.80% | -0.91% | -84.71% | 15.30 M USD | ||
| 4715 | LEXX Lexaria Bioscience Corp. - Common Stock | 0.59 USD | 0.00% | +7.27% | -1.67% | -27.16% | 14.62 M USD | ||
| 4717 | TPST Tempest Therapeutics, Inc. - Common Stock | 0.98 USD | 0.00% | 0.00% | -21.60% | -59.00% | 14.51 M USD | ||
| 4720 | PASG Passage Bio, Inc. - Common Stock | 4.44 USD | -0.45% | -9.76% | -21.69% | -49.77% | 14.24 M USD |